1988

amfAR’s Terry Beirn helps muster support for, and Congress passes, the first comprehensive AIDS legislation—the Hope Act of 1988.

amfAR funds research to evaluate the effectiveness of pilot needle exchange programs in San Francisco and Portland, Oregon. These early studies indicate that making sterile syringes available can help reduce HIV infection rates among injection drug users.

In New York City, new AIDS cases that result from shared needles exceed those attributable to sexual contact, and the city’s Health Department begins an experimental needle exchange program.

ACT UP demonstrates at FDA headquarters to protest the slow pace of AIDS drug approval.

The federal government mails an educational pamphlet, “Understanding AIDS,” to 107 million homes nationwide.

amfAR funds the nation’s first two community-based AIDS clinical trials units in New York City and San Francisco.

Dr. Ruth Ruprecht receives an amfAR grant to test whether AZT can prevent mother-to-infant transmission of an HIV-like virus in monkeys. (See 1994.)

amfAR grantee Dr. Ruth Ruprecht (Photo: Graham MacIndoe)

Anthony Fauci, M.D., is named acting director of NIH’s new Office of AIDS Research.

The World Health Organization designates December 1 as World AIDS Day.

amfAR Founding Board member Peter Scott, Esq., dies of AIDS.

U.S. YEAR-END STATISTICS

82,362 cases of AIDS reported to date
61,816 deaths